CONMED Corp (CNMD): Market Cap to Revenue

Symbol and logo of brand CONMED Corp (CNMD)

CONMED Corporation is integrating automation into surgery to reduce the workload on physicians. Medical loyalty to the tools allows the brand to exercise flexible pricing power, while stable demand for consumables ensures a consistent cash flow. The revenue multiple trend illustrates the market's valuation of the business's maturity, where 1.10 determines the current value of the indicator by comparing market capitalization with actual sales.

CNMD CONMED Corp P/S Multiple (07/04/2022 - 11/15/2026)

Analytical breakdowns for conmed.com (CNMD)

- share price and consensus valuation forecast:
- stock exchange capitalization data:
General company analysis:CNMD CONMED Corp
Core merchandise of CONMED Corporation

To minimize risks, an investor must compare the market value of CONMED Corporation (CNMD) with its annual revenue, utilizing the company's current P/S ratio to identify whether the asset is overvalued or undervalued. Stable cash flow and full coverage of liabilities confirm the fundamental resilience of the business, turning this indicator into an objective tool for verifying the fairness of quotes relative to actual sales volumes.

Competitors of CONMED Corporation

DXCM (DexCom Inc) - Market Capitalization-to-Revenue Ratio|P/S Multiple PEN (penumbrainc.com)|NOVT - Market Cap to Revenue|Haemonetics - P/S Multiple|Price to Sales Inspire Medical Systems|PRCT: P/S Multiple|Market Cap to Revenue Ratio PLSE|INMD (InMode MD) - P/S Multiple|Market Cap to Revenue Picard Medical Inc. (PMI)|P/S Multiple SRDX|Market Cap to Revenue Senseonics Holdings SENS|P/S Multiple NPCE (neuropace.com)|P/S Multiple Tactile Systems Technology TCMD|SNWV - Price-to-Revenue Ratio|Price to Sales Outset Medical Corp|ELMD (Electromed Inc) - Market Cap to Revenue|LENSAR, Inc. - Market Capitalization-to-Revenue Ratio|RCEL (AVITA Medical Inc) - P/S Multiple|Price to Sales profoundmedical.com PROF|Price-to-Revenue Ratio Baird Medical (BDMD)|EDAP Medical (EDAP) - Price-to-Revenue Multiple|Apyx Medical Corp - Market Cap to Revenue|P/S Multiple IceCure Medical, Ltd. ICCM|Pulmonx Corp - P/S Multiple|Price-to-Revenue Coefficient TELA Bio TELA|CytoSorbents Corporation (CTSO) - Price-to-Revenue Ratio|Price-to-Sales Ratio SRTS (Sensus)|Price-to-Revenue Ratio zynex.com|Market Cap to Revenue electroCore, Inc. (ECOR)|P/S Multiple RBOT|IINN - Price to Sales|SeaStar Medical - Market Cap to Revenue|IRIX: Market Cap to Revenue Ratio|INBS: Market Cap to Revenue|beyondair.net - Market Cap to Sales Volume|Profusa Inc (PFSA) - Price-to-Revenue Ratio|SSKN - Price-to-Revenue Coefficient|Price-to-Revenue Ratio GlucoTrack|P/S Multiple NanoVibronix Inc.|Price-to-Revenue Ratio Venus Concept (VERO)|Market Cap to Revenue Nuwellis, Inc. NUWE|P/S Multiple AEMD (Aethlon Medical, Inc.)|ASXC: Market Cap to Revenue Ratio|Avinger Inc. - P/S Multiple|Price-to-Revenue Coefficient BioSig Technologies, Inc BSGM|CUTR: P/S Multiple|Know Labs, Inc. (KNW) - P/S Multiple|Price-to-Revenue Ratio Inari Medical Inc|Market Cap to Revenue Nevro Corp (NVRO)|Market Cap to Revenue RSLS (ReShape Lifesciences, Inc.)|P/S Multiple Silk Road Medical Inc. (SILK)